BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10092013)

  • 41. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
    J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.
    Yuki N; Hayashi N; Mita E; Hagiwara H; Oshita M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Feb; 45(2):162-7. PubMed ID: 7539828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The establishment of antigen sandwiched ELISA for detection of total antibodies to hepatitis C virus].
    Hong S; Mao P; He H; Fu T; Liu H; Bai Y; Yang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):375-7. PubMed ID: 15617253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Ueda K; Fusamoto H; Kamada T
    J Med Virol; 1992 Oct; 38(2):86-91. PubMed ID: 1334132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
    Tallo T; Lappalainen M; Tefanova V; Priimägi I
    Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.
    Lin S; Arcangel P; Medina-Selby A; Coit D; Ng P; Nguyen S; McCoin C; Gyenes A; Hu C; Tandeske L; Phelps B; Chien D
    J Clin Microbiol; 2005 Aug; 43(8):3917-24. PubMed ID: 16081931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types.
    Tisminetzky S; Gerotto M; Pontisso P; Chemello L; Prescott LE; Rose KA; Baralle F; Simmonds P; Alberti A
    J Virol Methods; 1995 Nov; 55(3):303-7. PubMed ID: 8609196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.
    Galal IF; Zakaria Z; Allam WR; Mahmoud MA; Ezzat AR; Osman A; Waked I; Strickland GT; Abdelwahab SF
    PLoS One; 2014; 9(6):e101264. PubMed ID: 24979366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
    Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection.
    Jolivet-Reynaud C; Dalbon P; Viola F; Yvon S; Paranhos-Baccala G; Piga N; Bridon L; Trabaud MA; Battail N; Sibai G; Jolivet M
    J Med Virol; 1998 Dec; 56(4):300-9. PubMed ID: 9829633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.
    Bhattacherjee V; Prescott LE; Pike I; Rodgers B; Bell H; El-Zayadi AR; Kew MC; Conradie J; Lin CK; Marsden H
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1737-48. PubMed ID: 9049379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.